David Pyott

(Mr. David Pyott M.D.)

Currently holds a position at Biomarin Pharmaceutical Inc

Positions

Position Company Period
Independent Director Biomarin Pharmaceutical Inc Jan. 4, 2016 -
David Pyott's trades of Biomarin Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-25 2025-03-24
PS Planned sale
7,440 -98.2%
299.00
USD 2,224,560 		7,440 -98.2% 299.00 USD 2,224,560
2024-06-26 2024-06-24
PS Planned sale
7,470 -98.2%
222.00
USD 1,658,340 		7,470 -98.2% 222.00 USD 1,658,340
2024-06-26 2024-06-24
PS Planned sale
7,420 -49.4%
221.00
USD 1,639,820 		7,420 -49.4% 221.00 USD 1,639,820
2024-06-26 2024-06-24
PS Planned sale
17,560 -53.9%
220.00
USD 3,863,200 		17,560 -53.9% 220.00 USD 3,863,200
2020-09-01 2020-08-31
B Purchase
900 +3.0%
78.84
USD 70,955 		900 +3.0% 78.84 USD 70,955
2020-09-01 2020-08-31
B Purchase
11,900 +66.3%
78.22
USD 930,760 		11,900 +66.3% 78.22 USD 930,760
2020-02-05 2020-02-03
S Sale
5,027 -22.5%
132.72
USD 667,183 		5,027 -22.5% 132.72 USD 667,183
// ... existing code ... // ... rest of the file ...